Brief: Vistin Pharma Q2 EBITDA NOK 22 Million
20/08/2026 06:46
BRIEF-Vistin Pharma Q2 EBITDA NOK 22 Million Aug 20 (Reuters) - Vistin Pharma Q2 revenue NOK 100 million.
- Q2 net income NOK 14.1 million
- NOK815.94m
- NOK823.57m
- NOK452.29m
BRIEF-Vistin Pharma Q2 EBITDA NOK 22 Million Aug 20 (Reuters) - Vistin Pharma Q2 revenue NOK 100 million.